It takes a special kind of person to confront
challenges that seem insurmountable.
It takes grit, confidence and smarts.
Our dedicated team members are committed to engaging, empowering and bringing hope to those suffering from complex and challenging conditions.
Atsushi is President of Mitsubishi Tanabe Pharma America and Mitsubishi Tanabe Pharma Canada. He has more than 25 years of experience in the pharmaceutical industry and has been an integral member of Mitsubishi Tanabe group companies in America since 2009.
Prior to his current role, he was Vice President of Corporate Strategy and Operations at Mitsubishi Tanabe Pharma Holdings America, Inc. From 2012 to 2014, Atsushi served as Group Manager for US/EU Operations of the International Department for Mitsubishi Tanabe Pharma Corporation. He also worked at MTPA as Director of Corporate Strategy and Marketing from 2008 to 2012. Prior to that time, Atsushi was a Manager at Mitsubishi Tanabe Pharma Corporation.
Atsushi holds a Bachelor of Agriculture from Hiroshima University, and a Master of Science in Management of Technology from Massachusetts Institute of Technology.
Andy serves as our country manager to oversee the operations and growth of the business in Canada, focused on bringing new treatments to the market for unmet medical needs, including rare diseases. He has more than 20 years of experience in the pharmaceutical industry.
Prior to joining Mitsubishi Tanabe Pharma Canada, Andy served as head of the Canadian neuroscience business unit at Allergan. He was also Vice President of the Cardiovascular and Metabolic Business Unit at AstraZeneca Canada, and has extensive experience in sales, sales management, market access, marketing management and senior leadership, including launch and specialty care experience.
Andy holds a Bachelor of Arts in Social Science from the University of Western Ontario, and Post Graduate Teacher Certification from D’Youville College.
As Mitsubishi Tanabe Pharma America’s Vice President of Market Access, Kevin brings more than 30 years of commercial experience in the pharmaceutical and medical device industry, having served in a wide range of roles ranging from field sales to executive leadership.
Most recently, Kevin served as the Vice President of Market Access at Bioventus, where he was responsible for leading payer, trade, marketing, contracting, work compensation, and government teams. Prior to that, Kevin spent 6 years at Endo Pharmaceuticals, culminating in the role of Senior Director of Managed Markets. Earlier in his career, Kevin held roles in managed markets and sales at a number of pharmaceutical companies.
Kevin holds a Bachelor of Science in Forest Biology and Ichthyology from the State University of New York.
With two decades of experience in life sciences, Dr. Sam Shum is MTPA’s Vice President of Operations & Strategy, overseeing the company’s operational functions of Finance, Supply Chain, Quality Assurance, Public Affairs, Patient Engagement, Compliance Operations and Business Process and Strategy.
Before joining MTPA, Sam was Treasurer of Brookdale University Hospital and Medical Center in Brooklyn, NY, where he provided executive oversight for the hospital’s pharmacies, revenue cycle, contracting, 340B operations, procurement, accounting operations and treasury management. He also served as the liaison between the hospital system and New York State Department of Health. Previously, Sam held various operational, financial and engineering positions in diverse industries including life sciences, chemical, financial, consumer goods, and information systems.
Sam holds a Bachelor of Science in Mechanical Engineering from Polytechnic University and a Master of Business Administration in Finance from New York University. He holds a Doctor of Business Administration in Finance from Jack Welch College of Business at Sacred Heart University. His professional accreditations include Chartered Financial Analyst, Certified Public Accountant, Certified Management Accountant, Certified Financial Manager and Certified Treasury Professional.